KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Finished Goods (2020 - 2023)

Teladoc Health's Finished Goods history spans 4 years, with the latest figure at $26.3 million for Q1 2023.

  • For Q1 2023, Finished Goods fell 41.82% year-over-year to $26.3 million; the TTM value through Mar 2023 reached $26.3 million, down 41.82%, while the annual FY2022 figure was $32.0 million, 34.93% down from the prior year.
  • Finished Goods for Q1 2023 was $26.3 million at Teladoc Health, down from $32.0 million in the prior quarter.
  • Across five years, Finished Goods topped out at $49.1 million in Q4 2021 and bottomed at $26.3 million in Q1 2023.
  • The 4-year median for Finished Goods is $36.1 million (2020), against an average of $37.4 million.
  • The largest annual shift saw Finished Goods surged 38.53% in 2021 before it crashed 41.82% in 2023.
  • A 4-year view of Finished Goods shows it stood at $35.5 million in 2020, then soared by 38.53% to $49.1 million in 2021, then tumbled by 34.93% to $32.0 million in 2022, then decreased by 17.63% to $26.3 million in 2023.
  • Per Business Quant, the three most recent readings for TDOC's Finished Goods are $26.3 million (Q1 2023), $32.0 million (Q4 2022), and $36.8 million (Q3 2022).